Literature DB >> 3872908

Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.

B Heyman, M Nose, W O Weigle.   

Abstract

The in vitro immunosuppressive ability of a monoclonal IgG2b-anti-trinitrophenyl antibody lacking carbohydrate chains (GORK-Tm) has been compared with the immunosuppressive ability of the intact antibody (GORK). The carbohydrate depletion of GORK-Tm was achieved by culturing the GORK hybridoma cells in media containing tunicamycin, an inhibitor of glycosylation. Both antibodies have been shown to have the same antigen and protein A-binding capacity, although GORK-Tm is deficient in complement fixation, antibody-dependent cellular cytotoxicity, binding to Fc receptors on macrophages, and rapid elimination of antigen-antibody complexes from the circulation. It is shown in these studies that although GORK antibodies are efficient immunosuppressors, suppressing up to 95% of the plaque-forming cell response, GORK-Tm antibody preparations with identical hemagglutinating and antigen-binding capacity are highly deficient in suppressing the immune response. These findings are of interest in two ways. First, it shows that the carbohydrate chains are of great importance for the immunosuppressive effects of IgG. Secondly, it also shows that the isotype IgG2b, in addition to all other murine isotypes, can efficiently suppress the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872908

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 3.  Feedback regulation of antibody production: a role in rheumatoid arthritis?

Authors:  J K Kalsi; N D Hall
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.

Authors:  Dhohyung Kim; Devra Huey; Michael Oglesbee; Stefan Niewiesk
Journal:  Blood       Date:  2011-02-28       Impact factor: 22.113

5.  Detection of human asialo-alpha(1)-acid glycoprotein using a heterosandwich immunoassay in conjunction with the light addressable potentiometric sensor.

Authors:  K Dill; D W Bearden
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

Review 6.  The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.

Authors:  T W Rademacher; R B Parekh; R A Dwek; D Isenberg; G Rook; J S Axford; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1988

7.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

8.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].

Authors:  S Takei; Y K Arora; S M Walker
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Structural changes in the oligosaccharide moiety of human IgG with aging.

Authors:  K Shikata; T Yasuda; F Takeuchi; T Konishi; M Nakata; T Mizuochi
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

10.  Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.

Authors:  J S Axford; N Sumar; A Alavi; D A Isenberg; A Young; K B Bodman; I M Roitt
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.